![George Scangos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
George Scangos
Net worth: 28 M $ as of 30/12/2025
Profile
George A. Scangos is a businessperson who has been the head of 10 different companies and currently occupies the position of President, Chief Executive Officer & Director at Vir Biotechnology, Inc. He is also Member-National Board of Visitor at the University of California and on the board of 5 other companies. In his past career George A. Scangos held the position of Director at Decibel Therapeutics, Inc., Chief Executive Officer & Director at Biogen, Inc. Chief Executive Officer at Biogen Idec New Ventures, Inc. and Chief Executive Officer of Biogen Idec, Inc. (North Carolina) (both are subsidiaries of Biogen, Inc.), President, Chief Executive Officer & Director at Exelixis, Inc., President for Bayer Biotechnology, Chairman of Anadys Pharmaceuticals, Inc., Chairman of California Healthcare Institute, Senior Vice President-Research & Development at Bayer, Inc., President-Biotechnology Division at Bayer Corp., Chairman for Pharmaceutical Research & Manufacturers of America and Professor at The Johns Hopkins University. He received a doctorate from the University of Massachusetts and an undergraduate degree from Cornell University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2025 | 3,777,778 ( 2.72% ) | 23 M $ | 30/12/2025 | |
| 13/03/2025 | 38,386 ( 0.01% ) | 5 M $ | 30/12/2025 | |
| 02/06/2025 | 0 ( -.--% ) | - $ | 30/12/2025 |
George Scangos active positions
| Companies | Position | Start |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Director/Board Member | 08/05/2023 |
| AGILENT TECHNOLOGIES, INC. | Director/Board Member | 31/12/2010 |
Octave Bioscience, Inc.
 Octave Bioscience, Inc. Provides healthcare services | Director/Board Member | 11/07/2018 |
Biomedical Sciences Careers Program, Inc. | Director/Board Member | - |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
UC Davis School of Medicine
 UC Davis School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
IS Yatirim Menkul Degerler AS (Broker)
 IS Yatirim Menkul Degerler AS (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
University of California
 University of California Functions as a College/University | Corporate Officer/Principal | - |
Life Science Cares, Inc. | Director/Board Member | - |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Former positions of George Scangos
| Companies | Position | End |
|---|---|---|
| ░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░░ ░░░░░░ ░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of George Scangos
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 33 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in developing innovative therapies that target the molecular mechanisms that cause cancer | Health Technology |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Entelos, Inc.
 Entelos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial partner that supports drug research and development teams | Commercial Services |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Develops tuberculosis drugs | Health Technology |
Taconic Biosciences GmbH
 Taconic Biosciences GmbH Miscellaneous Commercial ServicesCommercial Services Researches genetics and functional genomics | Commercial Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer, Inc.
 Bayer, Inc. Chemicals: AgriculturalProcess Industries Manufactures chemicals, healthcare, agricultural, and life science products | Process Industries |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
California Healthcare Institute
 California Healthcare Institute BiotechnologyHealth Technology Provides biomedical community services | Health Technology |
Museum of Science
 Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Consumer Services |
Symphony Evolution, Inc.
 Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical drugs | Health Technology |
IS Yatirim Menkul Degerler AS (Broker)
IS Yatirim Menkul Degerler AS (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Biomedical Sciences Careers Program, Inc. | |
Fondation Santé | |
UC Davis School of Medicine
UC Davis School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
University of California Functions as a College/University | |
Baybio Institute | |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. Develops gene therapies for fatal and debilitating diseases of the central nervous system | |
Octave Bioscience, Inc.
Octave Bioscience, Inc. Provides healthcare services | |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. Operates as a biotechnology company which develops transformative treatments for hearing and balance disorders | |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. Develops cures and treatments drug for viral & bacterial diseases | |
Bayer Biotechnology | |
Life Science Cares, Inc. | |
Rezo Therapeutics, Inc.
 Rezo Therapeutics, Inc. Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence |
- Stock Market
- Insiders
- George Scangos
